InsiderDirector
Tal Zvi Zaks Insider Trading Activity
Every SEC Form 4 transaction reported by Tal Zvi Zaks, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is Tal Zvi Zaks buying or selling?
Tal Zvi Zaks reported 0 open-market buys ($0) and 74 sells ($124.2M) across 74 Form 4 filings at 2 companies — a net selling position of $124.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of Aug 10, 2026)
Total Form 4 filings
74
SEC EDGAR
Companies
2
Buys (0)
$0
Sells (74)
$124.2M
Insider sentiment
Net sellingNet insider flow of $124.2M in net selling, filed between Dec 17, 2019 – Aug 10, 2026.
Companies Tal Zvi Zaks files for
Recent Tal Zvi Zaks transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | TEVA | Director | Sale | 17 | $592.71 |
| Jul 2, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $1.2M |
| Jun 25, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $1.1M |
| Jun 21, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $1.0M |
| Jun 11, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $1.1M |
| Jun 3, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $919.5K |
| May 27, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $843.5K |
| May 20, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $778.7K |
| May 13, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $770.5K |
| May 11, 2021 | MRNA | Chief Medical Officer | Sale | 3.7K | $581.6K |
| May 4, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $932.3K |
| Apr 27, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $879.5K |
| Apr 20, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $815.2K |
| Apr 13, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $694.8K |
| Apr 6, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $648.5K |
| Mar 23, 2021 | MRNA | Chief Medical Officer | Sale | 1.2K | $173.6K |
| Mar 16, 2021 | MRNA | Chief Medical Officer | Sale | 10.0K | $1.4M |
| Mar 10, 2021 | MRNA | Chief Medical Officer | Sale | 16.5K | $2.1M |
| Mar 2, 2021 | MRNA | Chief Medical Officer | Sale | 10.0K | $1.5M |
| Feb 24, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $824.2K |
| Feb 9, 2021 | MRNA | Chief Medical Officer | Sale | 3.7K | $677.3K |
| Feb 2, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $811.7K |
| Jan 26, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $715.6K |
| Jan 20, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $619.4K |
| Jan 12, 2021 | MRNA | Chief Medical Officer | Sale | 5.0K | $585.6K |
Showing the 25 most recent filings of 74. Screen every filing.
Tal Zvi Zaks insider trading FAQ
Is Tal Zvi Zaks buying or selling?
Across 74 SEC Form 4 filings, Tal Zvi Zaks reported 0 open-market purchases totaling $0 and 74 sales totaling $124.2M — a net selling position of $124.2M.
Which companies does Tal Zvi Zaks file Form 4s for?
Tal Zvi Zaks has reported insider transactions at 2 companies, most often Moderna, Inc. (MRNA), TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
How far back does Tal Zvi Zaks's filing history go?
Trabud holds Tal Zvi Zaks's SEC Form 4 filings from Dec 17, 2019 – Aug 10, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Tal Zvi Zaks's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Tal Zvi Zaks and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener